Gestational diabetes mellitus (GDM) in the first-reported pregnancy modifies association between interpregnancy-weight-change and GDM risk in the subsequent pregnancy
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Background Weight change between pregnancies affects gestational diabetes mellitus (GDM) risk in subsequent pregnancies. However, it is unclear whether this impact differs based on the individual’s GDM status in a prior pregnancy. Objectives To evaluate whether prior GDM status modifies the association between interpregnancy-weight-change and GDM risk in a subsequent pregnancy. Study Design Using Vanderbilt Health's de-identified electronic health record, we identified 4574 individuals with at least 2 recorded pregnancies, with information available on GDM status and body mass index (BMI) at GDM screening. We computed interpregnancy-weight-change as the change in BMI at GDM screening between 2 consecutive-reported pregnancies. Using multivariable linear probability and binomial regression models, we evaluated the association between interpregnancy-weight-change and GDM risk in the second pregnancy, overall, and stratified by GDM status in the first pregnancy. We tested for effect measure modification by calculating the interaction contrast (IC) across the risk differences (RDs). We reported predicted risks for GDM, RD, and Differences in RD in the subsequent pregnancy between patients with and without GDM in their first-recorded pregnancy. Results On average, patients gained weight (BMI increased by 0.9 kg/m 2 ) between pregnancies and were more likely to have GDM in their second-recorded pregnancy (6.0% vs 4.4%). Individuals with GDM in their first pregnancy were more likely to have GDM in the second pregnancy compared to individuals without GDM in the first pregnancy (30.2% vs 5.0%). The excess risk of GDM for individuals who gained 5 BMI kg/m 2 (∼29 pounds [lbs] in patients with BMI of 27.1 kg/m 2 and height of 5 feet 4 inches) was substantially higher in those with GDM in their first pregnancy (RD=28.0%; 95% CI=19.1%, 36.9%) compared to those without GDM in their first pregnancy (RD=5.6%; 95% CI=3.8%, 7.4%). The IC was 22.4% (95% CI=13.4%, 31.5%; P <.001) across the RDs,. Similarly, the impact of weight loss (2 BMI units ∼ 12 lbs) on GDM risk reduction in the subsequent pregnancy was greater in individuals with prior GDM in their first pregnancy (RD=−3.9%; 95% CI=−0.7%, −7.2%), than among individuals without prior GDM in their first pregnancy (RD=−1.0%; 95% CI=−0.1%, −1.9%), with some evidence for effect measure modification (IC=−2.9%; 95% CI=−6.3%, 0.5%; P =.091). However, the predicted risk of subsequent GDM in women with prior history of GDM remains high (17.9% risk with 12 lbs weight loss and 15.4% with 29 lbs weight loss) despite substantial risk reduction. Conclusion Interpregnancy BMI increase is associated with an elevated risk of GDM in subsequent pregnancies for all individuals but is substantially pronounced in individuals with a history of GDM. Individuals with prior GDM may mitigate their risk through weight loss, but not sufficiently to reduce it to levels similar to those without GDM in their previous pregnancy. In counseling patients with a history of GDM considering a subsequent pregnancy, it is important to encourage weight loss for various reasons, while also emphasizing that the risk of GDM remains high even with weight loss.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Gestational diabetes mellitus (GDM) in the first-reported pregnancy modifies association between interpregnancy-weight-change and GDM risk in the subsequent pregnancy
- Date Crossref
- 01/05/2026
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
University of Nevada pays non établi dans la noticeUniversité ou école supérieure
-
Vanderbilt Health pays non établi dans la noticeEntreprise
-
Division of Quantitative and Clinical Sciences pays non établi dans la noticeÉtablissement de santé
-
Kirk Kerkorian School of Medicine pays non établi dans la noticeUniversité ou école supérieure
-
Department of Biostatistics pays non établi dans la noticeInstitution
-
Department of Biomedical Informatics pays non établi dans la noticeInstitution
-
Department of Obstetrics and Gynecology pays non établi dans la noticeInstitution
-
Division of Maternal and Fetal Medicine pays non établi dans la noticeInstitution
-
Division of Epidemiology pays non établi dans la noticeInstitution
University of Nevada, Vanderbilt Health et Division of Quantitative and Clinical Sciences, avec 6 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.